BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 6229269)

  • 1. The significance of fibrinogen derivatives in plasma in human renal failure.
    Lane DA; Ireland H; Knight I; Wolff S; Kyle P; Curtis JR
    Br J Haematol; 1984 Feb; 56(2):251-60. PubMed ID: 6229269
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fibrinogen derivatives and platelet activation products in acute and chronic liver disease.
    Hughes RD; Lane DA; Ireland H; Langley PG; Gimson AE; Williams R
    Clin Sci (Lond); 1985 Jun; 68(6):701-7. PubMed ID: 2485273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma beta-thromboglobulin, fibrinopeptide A and B beta 15-42 antigen in relation to postoperative DVT, malignancy and stanozolol treatment.
    Douglas JT; Blamey SL; Lowe GD; Carter DC; Forbes CD
    Thromb Haemost; 1985 Apr; 53(2):235-8. PubMed ID: 2410995
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Relationship between fibrinopeptide A and fibrinogen/fibrin fragment E in thromboembolism, DIC and various non-thromboembolic diseases.
    Mombelli G; Monotti R; Haeberli A; Straub PW
    Thromb Haemost; 1987 Aug; 58(2):758-63. PubMed ID: 3672428
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Discrimination between platelet-mediated and coagulation-mediated mechanisms in a model of complex thrombus formation in vivo.
    Cadroy Y; Horbett TA; Hanson SR
    J Lab Clin Med; 1989 Apr; 113(4):436-48. PubMed ID: 2522978
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of kidney in the catabolic clearance of human platelet antiheparin proteins from rat circulation.
    Bastl CP; Musial J; Kloczewiak M; Guzzo J; Berman I; Niewiarowski S
    Blood; 1981 Feb; 57(2):233-8. PubMed ID: 6160892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Plasma concentrations of fibrinopeptide A, fibrinogen fragment B beta 1-42 and beta-thromboglobulin following total hip replacement.
    Lane DA; Ireland H; Wolff S; Grant R; Jennings S; Allen-Mersh T
    Thromb Res; 1982 Apr; 26(2):111-8. PubMed ID: 6180501
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sequence of fibrinogen proteolysis and platelet release after intrauterine infusion of hypertonic saline.
    Nossel HL; Wasser J; Kaplan KL; LaGamma KS; Yudelman I; Canfield RE
    J Clin Invest; 1979 Nov; 64(5):1371-8. PubMed ID: 500818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Secreted platelet proteins with antiheparin and mitogenic activities in chronic renal failure.
    Guzzo J; Niewiarowski S; Musial J; Bastl C; Grossman RA; Rao AK; Berman I; Paul D
    J Lab Clin Med; 1980 Jul; 96(1):102-13. PubMed ID: 6446588
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Activation of coagulation and fibrinolytic systems following stroke.
    Lane DA; Wolff S; Ireland H; Gawel M; Foadi M
    Br J Haematol; 1983 Apr; 53(4):655-8. PubMed ID: 6219694
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Plasma fibrinopeptide A, beta-thromboglobulin, and platelet factor 4 in diabetic retinopathy.
    Roy MS; Podgor MJ; Rick ME
    Invest Ophthalmol Vis Sci; 1988 Jun; 29(6):856-60. PubMed ID: 2967258
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet activation and fibrinopeptide formation in pulmonary hypertension.
    Schulman LL; Grossman BA; Owen J
    Chest; 1993 Dec; 104(6):1690-3. PubMed ID: 8252943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma beta-thromboglobulin and platelet factor 4 in patients with chronic renal failure and effect of hemodialysis.
    Endo Y; Mamiya S; Satoh M; Takahashi K; Harada T
    Tohoku J Exp Med; 1981 Dec; 135(4):349-58. PubMed ID: 6175048
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Circadian variations of plasma levels of blood coagulation/fibrinolysis molecular markers in progressive systemic sclerosis (PSS).
    Maeda M; Kachi H; Kitajima Y
    J Dermatol Sci; 1996 Oct; 13(1):18-24. PubMed ID: 8902649
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasma concentration of platelet-specific proteins and fibrinopeptide A in patients with artificial heart valves.
    Dudczak R; Niessner H; Thaler E; Lechner K; Kletter K; Frischauf H; Domanig E; Aicher H
    Haemostasis; 1981; 10(4):186-94. PubMed ID: 6454613
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Significance of the thrombin-antithrombin III complex in the diagnosis of pulmonary embolism and deep venous thrombosis--comparison with fibrinopeptide A, platelet factor 4 and beta-thromboglobulin].
    Blanke H; Praetorius G; Leschke M; Seitz R; Egbring R; Strauer BE
    Klin Wochenschr; 1987 Aug; 65(16):757-63. PubMed ID: 2958657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Radioimmunoassay of platelet factor 4 and beta-thromboglobulin: development and application to studies of platelet release in relation to fibrinopeptide A generation.
    Kaplan KL; Nossel HL; Drillings M; Lesznik G
    Br J Haematol; 1978 May; 39(1):129-46. PubMed ID: 78721
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Generation of forms of fragment E with differing thrombin-binding properties during digestion of fibrinogen by plasmin.
    Goodwin CA; Kakkar VV; Scully MF
    Biochem J; 1992 Feb; 281 ( Pt 3)(Pt 3):613-8. PubMed ID: 1531588
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The serial hemostasis-related changes in patients with cerebral infarction: comparison between progressing and non-progressing stroke.
    Ho CH; Hu HH; Wong WJ
    Thromb Res; 1989 Dec; 56(5):635-47. PubMed ID: 2534001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective study of haemostatic parameters in relation to the clinical course of myeloproliferative disorders.
    Wehmeier A; Fricke S; Scharf RE; Schneider W
    Eur J Haematol; 1990 Oct; 45(4):191-7. PubMed ID: 2146144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.